The Latest Advances in Staging and Treating Mesothelioma


Mesothelioma is a rare form of cancer that affects the tissue lining of organs, typically the lungs, heart or abdomen. The disease is caused by exposure to asbestos, a toxic mineral that was used in construction materials and vehicles before its dangers were widely known. Mesothelioma is a difficult cancer to diagnose and treat, as it often doesn't present symptoms until it has progressed to an advanced stage. However, recent advances in staging and treatment are giving patients and their families hope.

Advanced Staging Techniques

Staging is the process of determining how far a cancer has progressed. For mesothelioma patients, accurate staging is crucial to determining the best course of treatment. In the past, mesothelioma staging was limited to imaging tests like x-rays and CT scans. However, newer techniques like PET scans and MRI scans are proving to be much more effective. PET scans use a radioactive tracer to identify areas of the body with active cancer cells. This can help doctors identify metastatic mesothelioma, or mesothelioma that has spread to other parts of the body. MRI scans use magnetic fields to create detailed images of organs and tissues. This can help doctors identify the exact location and size of mesothelioma tumors, which can be difficult to see on other imaging tests.

Improved Surgical Techniques

Surgery is often used to treat mesothelioma, particularly in early-stage cases. However, traditional surgical techniques like open surgery and video-assisted thoracoscopic surgery (VATS) can be invasive and have a long recovery time. Newer surgical techniques like robotic surgery and pleurectomy with decortication (P/D) are offering patients better outcomes. Robotic surgery is a minimally invasive technique that uses small incisions and a robot to perform the surgery. This can result in less scarring, less pain and a faster recovery time. P/D is a procedure that removes the affected lung lining and any tumorous tissue surrounding it. Unlike traditional surgery, which removes the entire lung, P/D allows patients to keep their lungs intact. This can improve overall lung function and quality of life.


Immunotherapy is a relatively new form of cancer treatment that uses the body's own immune system to fight cancer. Mesothelioma patients have historically had limited success with traditional cancer treatments like chemotherapy and radiation therapy. However, immunotherapy is showing promise in mesothelioma patients. Immunotherapy drugs like pembrolizumab and nivolumab work by activating the body's immune system to attack cancer cells. Studies have shown that some mesothelioma patients have responded well to immunotherapy, with improved survival rates and fewer side effects compared to traditional treatments.


While mesothelioma remains a challenging disease to diagnose and treat, recent advances in staging and treatment are offering patients and their families new hope. PET and MRI scans are providing more accurate staging information, while newer surgical techniques like robotic surgery and P/D are improving outcomes for patients. And immunotherapy is showing promise in a disease that has historically been difficult to treat. If you or a loved one has been diagnosed with mesothelioma, it's important to work closely with your healthcare team to determine the best treatment plan for you. With the latest advances in staging and treatment, there is reason to be hopeful.